«Malignancy Cancer

Below is an extended Malignancy Cancer patents listing. Click here to return to the Malignancy Cancer main in depth entry.

Patents :
US Patent No.	Title
6942992	Nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides
7105649	Gasci gene
7109301	Tenascin-C isoform as marker for neoplasias
7122360	Polypeptides, polynucleotides and uses thereof
7123762	Method and system for risk-modulated diagnosis of disease
7125872	.beta.-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
7128877	Methods and devices for obtaining and assaying mammary fluid samples for evaluating breast diseases, including cancer
7153846	Bengamide derivatives, process for preparing them, and their use
7187789	Prospective abnormal shadow detecting system, and method of and apparatus for judging whether prospective abnormal shadow is malignant or benignant
7192718	Methods for identifying a substance which specifically binds to an osteoclastogenesis inhibitory factor-binding molecule and modulates the biological activity thereof
7220824	Integrin-mediated drug targeting
7091310	Chemokine analogs for the treatment of human disease
7070931	Cancer control
7067272	Thin membrane for measuring protease activity
6974672	Gene amplification in cancer
6981950	Noninvasive intraductal fluid sampling device
6987004	Genes integrating signal transduction pathways
7005499	Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
7026454	Neuroendocrine marker of prostate cancer and method for producing same
7037666	Methods for identifying modulators of the interaction between lap (latency associated peptide) and intergrin .alpha..sub.v.beta..sub.3 and medical use thereof
7038030	BIVM (basic, immunoglobulin-like variable motif-containing) gene, transcriptional products, and uses thereof
7045117	Method for tumor diagnosis comprising administering of palladium-substituted bacteriochlorophyll derivatives
7056506	Methods for detecting and inhibiting angiogenesis
7067117	Compounds and methods to inhibit or augment an inflammatory response
7232828	PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
7238711	Compounds and methods to inhibit or augment an inflammatory response
7358045	Methods for determining a predisposition to develop breast adenocarcinoma or breast inflammatory carcinoma
7361336	Methods of cancer therapy targeted against a cancer stem line
7364736	Antibodies to OPGL
7381183	Method for capturing and displaying endoscopic maps
7381792	Variants of RANKL protein
7390633	Methods for preparing low molecular weight heparin with modified heparinase III
7390818	Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics
7396666	Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid
7399829	Variants of RANKL protein
7414073	Cytotoxic agents containing novel potent taxanes and their therapeutic use
7354928	Small molecule inhibitors targeted at Bcl-2
7348418	Carcinoma-related genes and polypeptides and methods of use thereof
7339065	Design and synthesis of optimized ligands for PPAR
7238786	Monoclonal antibody cPAM4
7247714	Protection against oxidative stress and inflammation by a cytoprotective response element
7253206	Phenalenone derivatives, processes for preparation and use thereof
7267961	Peptides from the E7 protein of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papilloma virus associated cancers
7274810	System and method for three-dimensional image rendering and analysis
7282567	Monoclonal antibody hPAM4
7306926	Method for detecting carcinomas in a solubilized cervical body sample
7311911	Methods for inhibiting angiogenesis
7316900	Methylated nucleotide regulation of gene expression
7316908	Peptides from the E2 proteins of human papillomaviruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers
7417124	Antibodies specific for phosphorylation sites and screening methods using the same antibodies

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.